Paraneoplastic syndromes

Archives of Neurology

Volumn 56, Issue 4, 1999, Pages 405-408

  Dalmau, Josep O ^a,b   Posner, Jerome B ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER ANTIBODY; NUCLEAR PROTEIN; TUMOR ANTIGEN; TUMOR PROTEIN;

ANTIBODY TITER; CANCER DIAGNOSIS; CANCER LOCALIZATION; CARCINOGENESIS; DISEASE ASSOCIATION; HUMAN; MOLECULAR CLONING; NERVE CELL DIFFERENTIATION; PARANEOPLASTIC SYNDROME; PRIORITY JOURNAL; PROTEIN ANALYSIS; REVIEW; TISSUE DISTRIBUTION; TUMOR GROWTH;

EID: 0032920998     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.56.4.405     Document Type: Review

References (17)

1. Dalmau JO, Posner JB. Neurological paraneoplastic syndromes. Neuroscientist. 1998:4:443-453.
2. Graus F, Dalmau JO, Rene R, et al. Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival. JClin Oncol. 1997;15:2866-2872.
3. Carpentier AF, Rosenfeld MR, Delattre JY, Whalen RG, Posner JB, Dalmau JO. DNA vaccination with HuD inhibits growth of a neuroblastoma in mice. Clin Cancer Res. 1998:4:2819-2824.
4. Vote R, Dalmau JO, Posner JB, Rosenfeld MR. T-cell receptor analysis in anti-Hu associated paraneoplastic encephalomyelitis. Neurology. 1998;51:1146-1150.
5. Dalmau JO, Furneaux HM, Rosenblum MK, Graus F, Posner JB. Detection of the anti-Hu antibody in specific regions of the nervous system and tumor from patients with paraneoplastic encephalomyelitis/sensory neuronopathy. Neurology. 1991:41:1757-1764.
6. Wilkinson PC, Zeromski J. Immunofluorescent detection of antibodies against neurons in sensory carcinomatous neuropathy. Brain. 1959:88:529-538.
7. Graus F, Cordon-Cardo C, Posner JB. Neuronal antinuclear antibody in sensory neuronopathy from lung cancer. Neurology. 1985:35:538-543.
8. Ma W-J, Cheng S, Campbell C, Wright A, Furneaux H. Cloning and characterization of HuR, a ubiquitously expressed ELAV-like protein. JBiolChem. 1996:271: 8144-8151.
9. Okano HJ, Darnell RB. A hierarchy of Hu RNA binding proteins in developing and adult neurons. JfJeurosci. 1997:17:3024-3037.
10. Goldman SA, Kirschenbaum B, Harrison-Restelli C, Thaler HT. Neuronal precursors of the adult rat subependymal zone persist into senescence, with no decline in spatial extent or response to BDNF. JNeurobiol. 1997:32:554-566.
11. Greenlee JE, Brashear HR. Antibodies to cerebellar Purkinje cells in patients with paraneoplastic cerebellar degeneration and ovarian carcinoma. Ann Neurol. 1983; 14:609-613.
12. Jaeckle KA, Graus F, Houghton A, et al. Autoimmune response of patients with paraneoplastic cerebellar degeneration to a Purkinje cell cytoplasmic protein antigen. AnnNeurol. 1985:18:592-600.
13. Dropcho EJ, Chen Y-T, Posner JB, et al. Cloning of a brain protein identified by autoantibodies from a patient with paraneoplastic cerebellar degeneration. Proc NatlAcadSci U S A. 1987;84:4552-4556.
14. Albert ML, Darnell JC, Bender A, Francisco LM, Bhardwaj N, Darnell RB. Tumorspecific killer cells in paraneoplastic cerebellar degeneration. NatMed. 1998:4: 1321-1324.
15. Dalmau JO, Gultekin SH, Voltz R, et al. Mal, a novel neuronal and testis-specific protein, is recognized by the serum of patients with paraneoplastic neurologic disorders. Brain. 1999:122:27-39.
16. Motomura M, Johnston I, Lang B, Vincent A, Newsom-Davis J. An improved diagnostic assay for Lambert-Eaton syndrome. J Neurol Neurosurg Psychiatry. 1995; 58:85-87.
17. Mason WP, Graus F, Lang B, et al. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthénie syndrome. Brain. 1997; 120:1279-1300.